← Back to Search

Donor milk for Breastfeeding (MGM Trial)

N/A

Waitlist Available

Led By Valerie Flaherman, MD, MPH

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 week and 1 month after enrollment

Awards & highlights

MGM Trial Summary

This trial will compare banked donor milk to formula for breastfeeding late preterm infants born in San Francisco to assess growth and impacts on the type of bacteria in the baby's intestine.

Eligible Conditions

Premature Baby
Growth Delay
Microbial Colonization
Breastfeeding
Breast Milk Substitute Intolerance

MGM Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 week and 1 month after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 week and 1 month after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week and 1 month after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Bifidobacteria

Clostridium

Lactobacillus

+1 more

MGM Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Donor milkActive Control1 Intervention

Pasteurized donor breast milk

Group II: Preterm infant formulaPlacebo Group1 Intervention

Preterm formula determined by clinical practice

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,503 Previous Clinical Trials

15,236,607 Total Patients Enrolled

University of California, DavisOTHER

910 Previous Clinical Trials

4,706,943 Total Patients Enrolled

Valerie Flaherman, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco

5 Previous Clinical Trials

4,115 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which demographic is eligible to partake in this clinical trial?

"This research is looking for late preterm newborns between 34 and 37 weeks gestation, who have breast milk intolerance and are aged 1 Hour to 96 Hours. Furthermore, participants must also be those in which the clinical team plans to start supplementation."

Answered by AI

Are geriatric patients being included in this clinical research?

"According to the criteria stipulated for this clinical trial, enrollees must be between 1 Hour and 96 Hours old. Additionally, there are 395 trials available for minors and 708 for those over 65 years of age."

Answered by AI

How many participants are there in this experiment?

"Affirmative. Clinicaltrials.gov confirms that this research project is currently recruiting participants, which first began on October 30th 2017 and was most recently updated on August 2nd 2022. The trial requires 48 subjects to be enrolled at one site."

Answered by AI

Is there still capacity to enroll participants in this clinical investigation?

"That is correct. According to clinicaltrials.gov, this research study which was initially published on October 30th 2017 is actively enrolling participants. 48 volunteers need to be enrolled at one site in particular."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Milk, Growth and Microbiota Study

2017. "The Milk, Growth and Microbiota Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03220282.